Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone for Treatment of Previously Untreated Light Chain Amyloidosis by Muchtar, Eli, Gertz, Morie A, Laplant, Betsy, Buadi, Francis K., Leung, Nelson, Peterson, Stephanie M., Bergsagel, P. Leif, Fonder, Amie, Hwa, Yi L., Hobbs, Miriam A., Helgeson, Dania Kaehlyn, Vossen, Alanna M., Gonsalves, Wilson I, Lacy, Martha Q., Kapoor, Prashant, Siddiqui, Mustaqeem A., Larsen, Jeremy, Warsame, Rahma M, Hayman, Suzanne R., Go, Ronald S., Dingli, David, Kourelis, Taxiarchis, Dispenzieri, Angela, Rajkumar, S. Vincent, Kumar, Shaji K.

Get full text

Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma by Kumar, Shaji K., Kapoor, Prashant, Laplant, Betsy, Phuong-Dung, Liang, Muchtar, Eli, Buadi, Francis K., Gonsalves, Wilson I, Malave, Gabriella C, Vossen, Alanna M., Dingli, David, Go, Ronald S., Warsame, Rahma M, Kourelis, Taxiarchis, Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Lust, John A., Lacy, Martha Q., Dispenzieri, Angela, Hayman, Suzanne R., Leung, Nelson, Rajkumar, S. Vincent, Gertz, Morie A.

Get full text